LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 79 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,891,000 | +14.8% | 924,831 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $6,004,000 | +1.3% | 863,583 | +19.9% | 0.00% | 0.0% |
| Q3 2016 | $5,926,000 | +5.6% | 720,363 | +4.0% | 0.00% | 0.0% |
| Q2 2016 | $5,611,000 | +64.8% | 692,784 | +3.4% | 0.00% | – |
| Q1 2016 | $3,405,000 | -34.0% | 670,103 | +0.2% | 0.00% | -100.0% |
| Q4 2015 | $5,163,000 | +53.9% | 668,897 | +14.9% | 0.00% | – |
| Q3 2015 | $3,355,000 | -22.4% | 582,225 | +23.5% | 0.00% | – |
| Q2 2015 | $4,326,000 | – | 471,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,188,331 | $15,209,000 | 19.14% |
| ACUTA CAPITAL PARTNERS, LLC | 3,809,944 | $26,479,000 | 9.85% |
| Avoro Capital Advisors LLC | 4,520,643 | $31,418,000 | 6.35% |
| Broadfin Capital, LLC | 2,638,259 | $18,336,000 | 2.04% |
| Perceptive Advisors | 3,567,553 | $24,794,000 | 1.76% |
| Ghost Tree Capital, LLC | 975,000 | $6,776,000 | 1.63% |
| Opaleye Management Inc. | 300,000 | $2,085,000 | 1.23% |
| Rhenman & Partners Asset Management AB | 650,000 | $4,518,000 | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $1,043,000 | 0.39% |
| QVT Financial LP | 1,498,809 | $10,349,000 | 0.31% |